Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Investigation Of a New Oral Anti-Histamine in Healthy Male Subjects [Phase 1]
Phase 1 update on an investigational oral antihistamine tested in healthy male volunteers. The trial addresses allergic rhinitis, including …
-
FDA approval · 2017-08-18FDA Approved: AZELASTINE — Original Application (Ascend Laboratories, LLC)
The FDA approved the original application for azelastine, a generic antihistamine, submitted by Ascend Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Nasal Provocation Testing in Occupational Rhinitis [NA]
Clinical trial update noting the completion of nasal provocation testing in occupational rhinitis.
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Dietary Intake in Adults From the GA2LEN Folow-up Survey
Completed clinical trial update evaluating dietary intake in adults from the GA2LEN follow-up survey, sponsored by Johns Hopkins Bloomberg S…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects [Phase 1]
Phase 1 first-in-human study of an intranasal H1/H3 dual antagonist in healthy male volunteers, evaluating single and repeat-dose administra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-07-31FDA Approved: BUDESONIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal Pharmaceuticals of New York LLC's original application for budesonide (generic). Budesonide is a corticosteroid used to …
-
CLINICAL_TRIALS research · 2017-07-26Clinical Trial Update: Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis
An observational study evaluating Oralair grass pollen immunotherapy in children aged 5-9 with grass pollen–induced allergic rhinitis with o…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: The Efficacy and Safety of Sanfujiu on Patients With Persistent Allergic Rhinitis: Randomized Controlled Study [Phase 3]
Phase 3 randomized trial evaluating the efficacy and safety of Sanfujiu for persistent allergic rhinitis. The update reports results from th…
-
FDA approval · 2017-07-21FDA Approved: ALLERGY RELIEF — Original Application (WALMART INC. (see also Equate))
FDA approved Walmart's ALLERGY RELIEF containing cetirizine hydrochloride as an original generic application (ANDA 205291) for allergy relie…
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Olopatadine Eye Drops and Allergy Skin Testing [NA]
This clinical trial update reports completion and posted results for a study of olopatadine eye drops and allergy skin testing in allergic r…
-
FDA approval · 2017-07-10FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) submitted by Chattem, Inc.
-
FDA approval · 2017-07-10FDA Approved: ALLERGY RELIEF CHILDRENS — Supplemental Application (CVS Pharmacy)
FDA approved a supplemental application for CVS Pharmacy's ALLERGY RELIEF CHILDRENS cetirizine hydrochloride product.
-
CLINICAL_TRIALS other · 2017-07-06Clinical Trial Update: House Dust Mite Injection Immunotherapy in Elderly Patients. [Phase 3]
A Phase 3 trial evaluating house dust mite injection immunotherapy in elderly patients has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate [Phase 4]
A Phase 4 trial update reports the completion of a study examining the molecular and cellular mechanisms of immunotherapy using a Phleum pra…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics. [Phase 1]
A Phase 1 study assessing safety, tolerability, PK and PD of GSK2245035 in healthy volunteers and individuals with seasonal allergic rhiniti…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Pharmacokinetic Study of Levocetirizine Oral Solution [Phase 1]
Phase 1 pharmacokinetic study of an oral levocetirizine solution in individuals with allergic rhinitis (perennial and seasonal); the trial i…
-
FDA approval · 2017-06-09FDA Approved: PSEUDOEPHEDRINE HCL — Original Application (Better Living Brands LLC)
FDA approved the original ANDA for pseudoephedrine HCl (Better Living Brands LLC), authorizing its marketing as an over-the-counter nasal de…
-
CLINICAL_TRIALS research · 2017-05-30Clinical Trial Update: Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting
A prospective observational study examining concomitant treatment patterns for allergic rhinitis among patients starting fluticasone furoate…
-
FDA approval · 2017-05-22FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Chewable Grape and Bubblegum (loratadine) from Bayer HealthCare LLC. The approval expan…
-
FDA approval · 2017-05-19FDA Approved: CYPROHEPTADINE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a generic cyproheptadine hydrochloride product from Zydus Pharmaceuticals USA Inc (ANDA 208938). Indications include relief of …
-
CLINICAL_TRIALS research · 2017-05-19Clinical Trial Update: "Studio NaVA" - National Study on Quality of Life in Adolescents Affected by Allergic Rhinitis With or Without Asthma
Notes the completion of Studio NaVA, a national study assessing quality of life in adolescents with allergic rhinitis with or without asthma…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of Birch pollen extract immunotherapy for allergic rhinitis has completed.
-
FDA approval · 2017-05-16FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)
FDA approved a supplemental application for Claritin RediTabs (loratadine) from Bayer Healthcare LLC. Claritin RediTabs is an antihistamine …
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects [Phase 1]
A Phase 1 relative bioavailability study comparing two Montelukast sodium 5 mg chewable tablets to a reference 5 mg Montelukast chewable tab…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine [Phase 1]
A Phase 1 study assessing the relative bioavailability of intranasal fluticasone furoate and levocabastine has been completed. The trial inv…